In addition, a combination of doxorubicin and CD47 antibody treatment induced comparable anti-cancer effects in osteosarcoma to that induced by combine treatment of doxorubicin with BCH (Supplementary Fig. 17g). This evidence concerns the gene CD47 and osteosarcoma.